VYNE
VYNE Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$28.56
+0.00%Jul 21, 2026, 12:00 UTC
VYNE Therapeutics announced a 1-for-50 reverse stock split and a special dividend in connection with its proposed merger with Yarrow Bioscience.
Jul 10, 2026, 12:00 UTC
VYNE Therapeutics declared a special cash dividend of approximately $16.5 million ($0.38 per share) in connection with its proposed merger with Yarrow Bioscience.
Source: